The withdrawal comes after postmarketing studies showed that the risks of side effects were greater than the benefits.

Pfizer withdraws OXBRYTA after post marketing studies showed that the risks of side effects were greater than the benefits.

Pfizer’s abrupt withdrawal of Oxbryta, a drug for sickle cell disease, has sent shockwaves through the medical community.

Significant regulatory news last week included the US Food and Drug Administration (FDA) granting approval for Zevra ...

Goldman Sachs analyst Mark Delaney has maintained their bullish stance on JBL stock, giving a Buy rating on September 27. Mark Delaney’s ...

Sonos (SONO – Research Report) received a Hold rating and a $0.00 price target from Craig-Hallum analyst Alex Fuhrman on September 26.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Meta Fined $102M for Storing Facebook Passwords in Plain Text ...

Photo shows A bundle of bright backpacks sits on the ground with a child lying down in the middle in front of a group of huddled people ...

Phuket is a province in the south of Thailand. Phuket's beaches face the Andaman Sea allowing the west coast beaches fantastic sunsets right throughout the year. If ...

The Kritios Boy, a statue displayed at the Acropolis Museum is one of the most important works of ancient Greek art and the most characteristic of the so-called "Severe Style." The statue’s torso was ...